You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR FLUAD QUADRIVALENT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for FLUAD QUADRIVALENT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00911521 ↗ Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study Completed Tuen Mun Hospital Phase 4 2009-10-01 The purpose of this trial is to study the effect of Human Papillomavirus (HPV) vaccination on the elevation of antibody titer to 4 serotypes of HPV in patients with systemic lupus erythematous and compare the antibody response with an equal number of age-matched healthy women.
NCT00941889 ↗ The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata Completed Washington University School of Medicine N/A 2007-07-01 The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.
NCT01454986 ↗ Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects Completed Alexion Pharmaceuticals Phase 1 2011-11-01 The purpose of the study is to evaluate the safety, tolerability, PK and PD of a single-dose of ALXN1007 in healthy volunteers.
NCT01852942 ↗ Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV Completed Merck Sharp & Dohme Corp. Phase 2 2014-09-01 This study was designed to test the hypothesis that treatment of HIV infected subjects with losartan, an agent with specific anti-inflammatory and anti-fibrotic actions, will: 1. reverse existing lymphoid tissue fibrosis, 2. restore lymphoid tissue architecture, 3. increase the number and improve the function of peripheral and lymphatic CD4 T cells, 4. decrease levels of systemic immune activation (IA), 5. decrease size of the HIV reservoir, and 6. be safe and well tolerated.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for FLUAD QUADRIVALENT

Condition Name

Condition Name for FLUAD QUADRIVALENT
Intervention Trials
Influenza 9
HIV Infections 2
HIV Positive 1
Relapsing Forms of Multiple Sclerosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for FLUAD QUADRIVALENT
Intervention Trials
Influenza, Human 13
Asthma 3
Neoplasms 2
Carcinoma in Situ 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for FLUAD QUADRIVALENT

Trials by Country

Trials by Country for FLUAD QUADRIVALENT
Location Trials
United States 81
Australia 14
Canada 8
Philippines 5
China 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for FLUAD QUADRIVALENT
Location Trials
North Carolina 7
Georgia 6
Ohio 6
Texas 5
Missouri 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for FLUAD QUADRIVALENT

Clinical Trial Phase

Clinical Trial Phase for FLUAD QUADRIVALENT
Clinical Trial Phase Trials
Phase 4 5
Phase 3 8
Phase 2 8
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for FLUAD QUADRIVALENT
Clinical Trial Phase Trials
Completed 10
Recruiting 9
Not yet recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FLUAD QUADRIVALENT

Sponsor Name

Sponsor Name for FLUAD QUADRIVALENT
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 4
Merck Sharp & Dohme Corp. 3
The University of Hong Kong 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for FLUAD QUADRIVALENT
Sponsor Trials
Other 26
Industry 22
NIH 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.